Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance

Srivatsan S Kidambi, Rubin S. Yarmush, Eric Novik, Piyun Chao, Martin L. Yarmush, Yaakov Nahmias

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

The liver is a major site for the metabolism of xenobiotic compounds due to its abundant level of phase I/II metabolic enzymes. With the cost of drug development escalating to over $400 million/ drug there is an urgent need for the development of rigorous models of hepatic metabolism for preclinical screening of drug clearance and hepatotoxicity. Here, we present a microenvironment in which primary human and rat hepatocytes maintain a high level of metabolic competence without a long adaptation period. We demonstrate that co-cultures of hepatocytes and endothelial cells in serum-free media seeded under 95% oxygen maintain functional apical and basal polarity, high levels of cytochrome P450 activity, and gene expression profiles on par with freshly isolated hepatocytes. These oxygenated co-cultures demonstrate a remarkable ability to predict in vivo drug clearance rates of both rapid and slow clearing drugs with an R2 of 0.92. Moreover, as the metabolic function of oxygenated co-cultures stabilizes overnight, preclinical testing can be carried out days or even weeks before other culture methods, significantly reducing associated labor and cost. These results are readily extendable to other culture configurations including three-dimensional culture, bioreactor studies, as well as microfabricated co-cultures.

Original languageEnglish (US)
Pages (from-to)15714-15719
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume106
Issue number37
DOIs
StatePublished - Sep 15 2009

Fingerprint

Coculture Techniques
Hepatocytes
Oxygen
Gene Expression
Pharmaceutical Preparations
Preclinical Drug Evaluations
Drug Costs
Aptitude
Liver
Serum-Free Culture Media
Bioreactors
Xenobiotics
Transcriptome
Mental Competency
Cytochrome P-450 Enzyme System
Endothelial Cells
Costs and Cost Analysis
Enzymes

Keywords

  • Drug discovery
  • Liver metabolism
  • Tissue engineering

ASJC Scopus subject areas

  • General

Cite this

Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance. / Kidambi, Srivatsan S; Yarmush, Rubin S.; Novik, Eric; Chao, Piyun; Yarmush, Martin L.; Nahmias, Yaakov.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 37, 15.09.2009, p. 15714-15719.

Research output: Contribution to journalArticle

@article{fef8502b68cd4ca5ab8ef81aa1757848,
title = "Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance",
abstract = "The liver is a major site for the metabolism of xenobiotic compounds due to its abundant level of phase I/II metabolic enzymes. With the cost of drug development escalating to over $400 million/ drug there is an urgent need for the development of rigorous models of hepatic metabolism for preclinical screening of drug clearance and hepatotoxicity. Here, we present a microenvironment in which primary human and rat hepatocytes maintain a high level of metabolic competence without a long adaptation period. We demonstrate that co-cultures of hepatocytes and endothelial cells in serum-free media seeded under 95{\%} oxygen maintain functional apical and basal polarity, high levels of cytochrome P450 activity, and gene expression profiles on par with freshly isolated hepatocytes. These oxygenated co-cultures demonstrate a remarkable ability to predict in vivo drug clearance rates of both rapid and slow clearing drugs with an R2 of 0.92. Moreover, as the metabolic function of oxygenated co-cultures stabilizes overnight, preclinical testing can be carried out days or even weeks before other culture methods, significantly reducing associated labor and cost. These results are readily extendable to other culture configurations including three-dimensional culture, bioreactor studies, as well as microfabricated co-cultures.",
keywords = "Drug discovery, Liver metabolism, Tissue engineering",
author = "Kidambi, {Srivatsan S} and Yarmush, {Rubin S.} and Eric Novik and Piyun Chao and Yarmush, {Martin L.} and Yaakov Nahmias",
year = "2009",
month = "9",
day = "15",
doi = "10.1073/pnas.0906820106",
language = "English (US)",
volume = "106",
pages = "15714--15719",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "37",

}

TY - JOUR

T1 - Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance

AU - Kidambi, Srivatsan S

AU - Yarmush, Rubin S.

AU - Novik, Eric

AU - Chao, Piyun

AU - Yarmush, Martin L.

AU - Nahmias, Yaakov

PY - 2009/9/15

Y1 - 2009/9/15

N2 - The liver is a major site for the metabolism of xenobiotic compounds due to its abundant level of phase I/II metabolic enzymes. With the cost of drug development escalating to over $400 million/ drug there is an urgent need for the development of rigorous models of hepatic metabolism for preclinical screening of drug clearance and hepatotoxicity. Here, we present a microenvironment in which primary human and rat hepatocytes maintain a high level of metabolic competence without a long adaptation period. We demonstrate that co-cultures of hepatocytes and endothelial cells in serum-free media seeded under 95% oxygen maintain functional apical and basal polarity, high levels of cytochrome P450 activity, and gene expression profiles on par with freshly isolated hepatocytes. These oxygenated co-cultures demonstrate a remarkable ability to predict in vivo drug clearance rates of both rapid and slow clearing drugs with an R2 of 0.92. Moreover, as the metabolic function of oxygenated co-cultures stabilizes overnight, preclinical testing can be carried out days or even weeks before other culture methods, significantly reducing associated labor and cost. These results are readily extendable to other culture configurations including three-dimensional culture, bioreactor studies, as well as microfabricated co-cultures.

AB - The liver is a major site for the metabolism of xenobiotic compounds due to its abundant level of phase I/II metabolic enzymes. With the cost of drug development escalating to over $400 million/ drug there is an urgent need for the development of rigorous models of hepatic metabolism for preclinical screening of drug clearance and hepatotoxicity. Here, we present a microenvironment in which primary human and rat hepatocytes maintain a high level of metabolic competence without a long adaptation period. We demonstrate that co-cultures of hepatocytes and endothelial cells in serum-free media seeded under 95% oxygen maintain functional apical and basal polarity, high levels of cytochrome P450 activity, and gene expression profiles on par with freshly isolated hepatocytes. These oxygenated co-cultures demonstrate a remarkable ability to predict in vivo drug clearance rates of both rapid and slow clearing drugs with an R2 of 0.92. Moreover, as the metabolic function of oxygenated co-cultures stabilizes overnight, preclinical testing can be carried out days or even weeks before other culture methods, significantly reducing associated labor and cost. These results are readily extendable to other culture configurations including three-dimensional culture, bioreactor studies, as well as microfabricated co-cultures.

KW - Drug discovery

KW - Liver metabolism

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=70349466841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349466841&partnerID=8YFLogxK

U2 - 10.1073/pnas.0906820106

DO - 10.1073/pnas.0906820106

M3 - Article

VL - 106

SP - 15714

EP - 15719

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 37

ER -